The pharmacology of cocaethylene in humans following cocaine and ethanol administration

Drug and Alcohol Dependence

Volumn 72, Issue 2, 2003, Pages 169-182

  Harris, Debra S ^a   Everhart, E Thomas ^a   Mendelson, John ^a   Jones, Reese T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cocaethylene; Cocaine; Ethanol; Pharmacokinetics; Pharmacology

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZOYLECGONINE; CANNABIS; COCAINE; DEUTERIUM; DIAZEPAM; ECGONINE; HOMOCOCAINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL;

EID: 0242551164     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00200-X     Document Type: Article

References (41)

1. Abreu M.E., Bigelow G.E., Fleisher L., Walsh S.L. Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology (Berlin). 154:2001;76-84.
2. Andrews P. Cocaethylene toxicity. J. Addict. Dis. 16:1997;75-84.
3. Bailey D.N. Cocaine and cocaethylene binding to human tissues - a preliminary study. Ther. Drug Monit. 18:1996;280-283.
4. Bakir A.A., Dunea G. Drugs of abuse and renal disease. Curr. Opin. Nephrol. Hypertens. 5:1996;122-126.
5. Bell M.R., Archer S. L(+)-2-tropanone. J. Am. Chem. Soc. 82:1960;4642.
6. Benowitz N.L., Jacob P. III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin. Pharmacol. Ther. 56:1994;483-493.
7. Bosin T.R., Garbrecht F.C., Raymond M.G. Preparation of deuterium-labeled cocaine and benzoylecgonine. Res. Commun. Chem. Pathol. Pharmacol. 11:1975;405-411.
8. Bosron W.F., Dean R.A., Brzezinski M.R., Pindel E.V. Human liver cocaine carboxylesterases. NIDA Res. Monogr. 173:1997;27-34.
9. Bradberry C.W., Nobiletti J.B., Elsworth J.D., Murphy B., Jatlow P., Roth R.H. Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J. Neurochem. 60:1993;1429-1435.
10. Bradberry C.W., Lee T., Jatlow P. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence. Psychopharmacology (Berlin). 146:1999;87-92.
11. Dean R.A., Bosron W.F., Zachman F.M., Zhang J., Brzezinski M.R. Effects of ethanol on cocaine metabolism and disposition in the rat. NIDA Res. Monogr. 173:1997;35-47.
12. Dolinsky Z.S., Babor T.F. Ethical, scientific and clinical issues in ethanol administration research involving alcoholics as human subjects. Addiction. 92:1997;1087-1097.
13. Eisenberg M.J., Yakel D.L., Mendelson J., Redberg R.F., Jones R.T., Foster E. Immediate effects of intravenous cocaine on the thoracic aorta and coronary arteries. A transesophageal echocardiographic study. Chest. 110:1996;147-154.
14. Elman I., Krause S., Karlsgodt K., Schoenfeld D.A., Gollub R.L., Breiter H.C., Gastfriend D.R. Clinical outcomes following cocaine infusion in nontreatment-seeking individuals with cocaine dependence. Biol. Psychiatry. 49:2001;553-555.
15. Everhart E.T., Jacob P. III, Mendelson J., Jones R.T. The synthesis of deuterium-labelled cocaine, cocaethylene and metabolites. J. Label. Compd. Radiopharm. 42:1999;1265-1275.
16. Farre M., De La Torre R., Llorente M., Lamas X., Ugena B., Segura J., Cami J. Alcohol and cocaine interactions in humans. J. Pharmacol. Exp. Ther. 266:1993;1364-1373.
17. Farre M., De La Torre R., Gonzalez M.L., Teran M.T., Roset P.N., Menoyo E., Cami J. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J. Pharmacol. Exp. Ther. 283:1997;164-176.
18. Gibaldi M., Perrier D. Pharmacokinetics. second ed:1982;Marcel Dekker, New York.
19. Grant B.F., Harford T.C. Concurrent and simultaneous use of alcohol with cocaine: Results of national survey. Drug Alcohol Depend. 25:1990;97-104.
20. Hart C.L., Jatlow P., Sevarino K.A., McCance-Katz E.F. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology (Berlin). 149:2000;153-162.
21. Hearn W.L., Flynn D.D., Hime G.W., Rose S., Cofino J.C., Mantero-Atienza E., Wetli C.V., Mash D.C. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J. Neurochem. 56:1991;698-701.
22. Hearn W.L., Rose S., Wagner J., Ciarleglio A., Mash D.C. Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol. Biochem. Behav. 39:1991;531-533.
23. Hedaya M.A., Pan W.J. Effect of alcohol coadministration on the plasma and brain concentrations of cocaine in rats. Drug Metab. Dispos. 25:1997;647-650.
24. Hime G.W., Hearn W.L., Rose S., Cofino J. Analysis of cocaine and cocaethylene in blood and tissues by GC-NPD and GC-ion trap mass spectrometry. J. Anal. Toxicol. 15:1991;241-245.
25. Jacob P. III, Elias-Baker B.A., Jones R.T., Benowitz N.L. Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. J. Chromatogr. 417:1987;277-286.
26. Kaufman M.J., Levin J.M., Ross M.H., Lange N., Rose S.L., Kukes T.J., Mendelson J.H., Lukas S.E., Cohen B.M., Renshaw P.F. Cocaine-induced cerebral vasocon-striction detected in humans with magnetic resonance angiography. J. Am. Med. Assoc. 279:1998;376-380.
27. McCance E.F., Price L.H., McDougle C.J., Kosten T.R., Black J.E., Jatlow P.I. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology. 111:1993;39-46.
28. McCance-Katz E.F., Kosten T.R., Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone - a multiple-dose study. Biol. Psychiatr. 44:1998;250-259.
29. Mendelson J.H., McGuire J., Mello N.K. A new device for administering placebo alcohol. Alcohol. 1:1984;417-419.
30. Morishima H.O., Whittington R.A., Iso A., Cooper T.B. The comparative toxicity of cocaine and its metabolites in conscious rats. Anesthesiology. 90:1999;1684-1690.
31. National Institute on Drug Abuse, 1989. National Household Survey on Drug Abuse: 1988 Population Estimates. DHHS Publication No. (ADM) 89-1636. Alcohol, Drug Abuse, and Mental Health Administration, Washington, DC.
32. Nzerue C.M., Hewan-Lowe K., Riley L.J. Jr. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives. Am. J. Kidney Dis. 35:2000;783-795.
33. Pan W.J., Hedaya M.A. Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects. J. Pharm. Sci. 88:1999;468-476.
34. Pan W.J., Hedaya M.A. Cocaine and alcohol interactions in the rat: effect of cocaine and alcohol pretreatments on cocaine pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 88:1999;1266-1274.
35. Perez-Reyes M. The order of drug administration: its effects on the interaction between cocaine and ethanol. Life Sci. 55:1994;541-550.
36. Perez-Reyes M., Jeffcoat A.R. Ethanol/cocaine interaction: cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sci. 51:1992;553-563.
37. Perez-Reyes M., Jeffcoat A.R., Myers M., Sihler K., Cook C.E. Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. Psychopharmacology. 116:1994;428-432.
38. Rafia F.D., Epstein R.L. Identification of cocaine and its metabolites in human urine in the presence of ethyl alcohol. J. Anal. Toxicol. 3:1979;59-63.
39. Raven M.A., Necessary B.D., Danluck D.A., Ettenberg A. Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene. Exp. Clin. Psychopharmacol. 8:2000;117-124.
40. Rose S., Hearn W.L., Hime G.W., Wetli C.V., Ruttenber A.J., Mash D.S. Cocaine and cocaethylene concentrations in human post mortem cerebral cortex (abstract). Soc. Neurosci. Abstr. 16:1990;14.
41. Van der Woude F.J. Cocaine use and kidney damage. Nephrol. Dial. Transplant. 15:2000;299-301.